Section Five: Financial statements 5 notes to tHe ComPAny FInAnCIAL stAtements 42.
AdoPtIon oF new And revIsed stAndArds The impact on the Company of new and revised standards is the same as for the Group.
Details are given in Note 1 to the consolidated financialstatements.
43. sIGnIFICAnt ACCountInG PoLICIes The separate financial statements of the Company are presented as required by the Companies Act 2006.
As permitted by that Act, the separate financial statements have been prepared in accordance with International Financial Reporting Standards and UK company law.
The financial statements have been prepared on the historical cost basis.
The principal accounting policies adopted are the same as those set out in Note 2 to the consolidated financial statements with the addition of the policy as noted below.
Investments in subsidiaries are stated at cost less, where appropriate, provisions for impairment.
Investment In suBsIdIArIes Investment in subsidiaries represents the following: ownership % ownership % ordinary shares ordinary shares Companys name established in 2010 2009 Hikma Limited uk 100 100 Hikma Pharma Limited Jersey 100 100 Hikma Holdings uk Limited uk 100 100 Al Jazeera Pharmaceutical Industries Ltd JPI k. s. A.
52.5 52.5 Hikma Pharmaceuticals Limited Jordan 22.8 22.8 The investments in subsidiaries are all stated at cost.
The remaining shares are held by other Group companies.
45. due From suBsIdIArIes As at 31 december 2010 2009 non-current assets $000 $000 Hikma Investment 8,269 8,160 west-ward Pharmaceuticals Corp 8,801 8,424 Hikma Italia s. p. A 3,606 4,420 Hikma Pharma Limited Jersey 2,119 5,674 22,795 26,678 These balances represent loans that carry interest of 1.3% to 4.8% 2009: 2.2% to 4.8% per annum charged on the outstanding loan balances.
As at 31 december 2010 2009 Current assets $000 $000 due from Hikma Pharma Limited Jersey 7,221 4,431 due from Hikma Farmaceutica Portugal 165 445 due from Hikma Pharma Germany 86 883 due from Hikma uk Limited 94,723 96,707 due from Hikma Limited 307 306 others 971 1,544 103,473 104,316 123
